Macarbi CH 40mg/12.5mg Tablet
By Macarbi CH
Rx
10 Tablet in a Strip

Composition
Azilsartan medoxomil(40mg) + Chlorthalidone(12.5mg)

Manufacturer - Macleods Pharmaceuticals Pvt Ltd
Atlanta Arcade, Marol Church Road, Andheri (East), Mumbai - 400059, INDIA.

Expires on or after
June, 2026

liver
When using Macarbi CH 40mg/12.5mg Tablet, it is important to be cautious if you have liver disease. Your doctor may need to adjust the dosage accordingly, so it is essential to consult them before taking this medication. It is not advisable to use Macarbi CH 40mg/12.5mg Tablet if you have severe liver disease.

kidney
Macarbi CH 40mg/12.5mg Tablet requires caution in severe kidney disease. Adjusting the dosage might be necessary. It is advised to consult with your doctor before use. Avoid in severe kidney disease.

alcohol
When consuming alcohol with Macarbi CH 40mg/12.5mg Tablet, be aware that it may lead to increased drowsiness.

driving
Avoid driving when taking Macarbi CH 40mg/12.5mg Tablet as it can reduce alertness, cause drowsiness, affect vision, or make you feel dizzy, which can impact your ability to drive safely.

pregnancy
Macarbi CH 40mg/12.5mg Tablet is not safe during pregnancy due to the risk it poses to the developing baby. Your doctor may only prescribe it in life-threatening situations if the benefits outweigh the risks. Please consult your doctor regarding its use.

breastfeeding
Macarbi CH 40mg/12.5mg Tablet is considered safe for breastfeeding mothers. Studies show that the medication has minimal transfer to breastmilk and is unlikely to harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹109
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024